cervical cancer
Biocon, Advaxis To Develop Cancer Immunotherapy Against HPV
Biocon and Advaxis will co-develop and commercialize ADXS-HPV, a novel cancer immunotherapy for the treatment of HPV.
Medifocus, Ideal Concept JV To Market Prolieve Treatment
Medifocus has entered into a joint venture agreement with Ideal Concept Group to sell and market its Prolieve treatment in China and other Asian countries.
Scientists Solve Mystery Of Cervical Cancer Cellular Origin
A team of scientists has identified a unique population of cells in the cervix from which cancerous cells arise after human papillomavirus infection.
‘Screen And Treat’ Model To Combat Cervical Cancer In Vietnamese Women
Researchers have found that widespread use of a “screen and treat” model is a successful strategy for cervical cancer prevention in Vietnam.
